Back to Search Start Over

ReCode Therapeutics Appoints Dean Mitchell as Chairman of Its Board of Directors

Source :
Entertainment Close-up. May 18, 2024
Publication Year :
2024

Abstract

ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, reported the appointment of Dean J. Mitchell as chairman [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Entertainment Close-up
Publication Type :
Periodical
Accession number :
edsgcl.794174771